publicaciones seleccionadas
-
documento
- Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
- Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
- Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
- In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
- Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
- PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication in vitro